Increased pulmonary RhoA expression in the nitrofen-induced congenital diaphragmatic hernia rat model.

[1]  D. Fitzgerald,et al.  Congenital diaphragmatic hernia , 2014, Journal of paediatrics and child health.

[2]  F. Friedmacher,et al.  Decreased apelin and apelin-receptor expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia , 2014, Pediatric Surgery International.

[3]  L. Sbragia,et al.  VEGF receptor expression decreases during lung development in congenital diaphragmatic hernia induced by nitrofen , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[4]  D. Tibboel,et al.  Standardized reporting for congenital diaphragmatic hernia--an international consensus. , 2013, Journal of pediatric surgery.

[5]  D. Tibboel,et al.  Premature differentiation of vascular smooth muscle cells in human congenital diaphragmatic hernia. , 2013, Experimental and molecular pathology.

[6]  S. Eaton,et al.  Trends in the treatment and outcome of congenital diaphragmatic hernia over the last decade , 2012, Pediatric Surgery International.

[7]  D. Tibboel,et al.  Management of Pulmonary Hypertension in Neonates with Congenital Diaphragmatic Hernia , 2012, European Journal of Pediatric Surgery.

[8]  Y. Sauve,et al.  Antenatal Sildenafil Treatment Attenuates Pulmonary Hypertension in Experimental Congenital Diaphragmatic Hernia , 2011, Circulation.

[9]  S. Aaronson,et al.  Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. , 2010, Genes & development.

[10]  Cheuk-Man Yu,et al.  Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. , 2010, Drug discovery today.

[11]  R. Webb,et al.  RhoA/Rho-kinase and vascular diseases: what is the link? , 2010, Cellular and Molecular Life Sciences.

[12]  W. Seeger,et al.  The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. , 2009, American journal of respiratory cell and molecular biology.

[13]  K. Komori,et al.  Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway , 2009, Surgery Today.

[14]  W. Xia,et al.  Acute Inhibition of Rho-Kinase Attenuates Pulmonary Hypertension in Patients with Congenital Heart Disease , 2009, Pediatric Cardiology.

[15]  P. Puri,et al.  Up-regulation of COUP-TFII gene expression in the nitrofen-induced hypoplastic lung. , 2009, Journal of pediatric surgery.

[16]  P. Kadowitz,et al.  Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[17]  B. Walker,et al.  Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[18]  L. Walker,et al.  Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[19]  F. Paradisi,et al.  Disturbance of retinol transportation causes nitrofen-induced hypoplastic lung. , 2007, Journal of pediatric surgery.

[20]  P. Puri,et al.  Down-regulation of Wnt signal pathway in nitrofen-induced hypoplastic lung. , 2007, Journal of pediatric surgery.

[21]  K. Morris,et al.  Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat. , 2006, Journal of applied physiology.

[22]  P. Pacaud,et al.  Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension , 2005, British journal of pharmacology.

[23]  A. Bejsovec.  Wnt Pathway Activation New Relations and Locations , 2005, Cell.

[24]  M. Oka,et al.  Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[25]  K. Kaibuchi,et al.  Long-Term Treatment With a Rho-Kinase Inhibitor Improves Monocrotaline-Induced Fatal Pulmonary Hypertension in Rats , 2004, Circulation research.

[26]  Randal P. Babiuk,et al.  Retinal dehydrogenase-2 is inhibited by compounds that induce congenital diaphragmatic hernias in rodents. , 2003, The American journal of pathology.

[27]  V. Gorgoulis,et al.  Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators. , 2002, The American journal of pathology.

[28]  E. Hay,et al.  DIRECT EVIDENCE FOR A ROLE OF β‐CATENIN/LEF‐1 SIGNALING PATHWAY IN INDUCTION OF EMT , 2002, Cell biology international.

[29]  Y. Taira,et al.  Comparison of the pulmonary vasculature in newborns and stillborns with congenital diaphragmatic hernia , 1998, Pediatric Surgery International.

[30]  C. Coppola,et al.  Endothelin-1 pulmonary vasoconstriction in rats with diaphragmatic hernia. , 1998, The Journal of surgical research.

[31]  R. Moon,et al.  Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development , 1996, The Journal of cell biology.

[32]  L. Wu,et al.  Pulmonary endothelial nitric oxide synthase gene expression is decreased in a rat model of congenital diaphragmatic hernia. , 1995, American journal of respiratory cell and molecular biology.

[33]  P. Puri,et al.  Upregulation of Endothelin Receptors A and B in the nitrofen induced hypoplastic lung occurs early in gestation , 2009, Pediatric Surgery International.

[34]  M. Oka,et al.  Rho kinase-mediated vasoconstriction in rat models of pulmonary hypertension. , 2008, Methods in enzymology.